www.bio-itworld.com Open in urlscan Pro
205.174.27.110  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 
 

 


 * Subscribe
 * News
   * Latest News
   * View Press Releases
   * Post a Press Release
   * Reprint Articles
 * Podcast
 * Advertise
   * Media Kit
   * Digital Advertising
   * Lead Generation
   * Editorial Calendar
   * Webinars
   * Whitepapers
   * Podcasts
   * View Press Releases
   * Post a Press Release
 * Free Downloads
   * Whitepapers
   * Podcasts
   * Webinars
   * Inside eBooks
 * Events
   * Webinars
   * Industry Events
   * IT Conferences
   * Bio-IT World Expo
   * Bio-IT World Expo Europe
 * About Us
   * Editorial Profile
   * Editorial Calender
   * Contact Us
   * Submit a story
   * Innovative Practices Awards
   * Linking Policy
 * Bio-IT World Expo
   * Bio-IT World Boston
   * Bio-IT World Europe

DAILY NEWS PRESS RELEASES


 * BIOASSAYS HAVE AN INTEGRATION PROBLEM: COLLABORATION WILL BE KEY TO MAKING
   THEM FAIR
   
   Feb 10 | Bio-IT World | Whilst life science companies have come to recognize
   data as their greatest asset, it is also their greatest challenge. Much of
   data is siloed in different formats and locations, making it difficult to
   discover, query, and share—rendering data essentially unusable. FAIR data
   must be rolled out across the entire industry if companies want to accelerate
   R&D and enable scientific queries to be answered more rapidly. More


 * BIOMEDICAL RESEARCH EXPERTS REACH CONSENSUS ON OPEN SCIENCE PRACTICES TO
   MONITOR INSTITUTIONS WORLDWIDE
   
   Feb 09 | Bio-IT World | A group of 80 research stakeholders convened to
   determine the best biomedical open science practices and create a fully
   automated dashboard to monitor their implementation. The team’s efforts will
   be used to improve research quality and foster innovation in the biomedical
   space. More


 * DEEPCELL RELEASES SAMPLE DATASETS TO HIGHLIGHT MORPHOLOGY-DRIVEN DATA
   
   Feb 07 | Bio-IT World | Deepcell, a pioneer in AI-powered single cell
   analysis to fuel deep biological discoveries, has released three datasets,
   available online, to enable researchers to explore novel high-dimensional
   morphology data. The datasets were generated on Deepcell’s high-throughput
   platform, comprised of imaging and sorting instrumentation, AI models, and a
   software suite. More


 * THE CARBON FOOTPRINT IMPACT OF CLOUD SOLUTIONS
   
   Feb 03 | Bio-IT World | While those in the life sciences appreciate the
   importance of curbing greenhouse gas emissions and the pressing impact of
   global warming, actionable steps toward going green have yet to permeate all
   facets of cloud computing research. As such, the current state of affairs in
   bioinformatic computing is not particularly green. More


 * 3D SPATIAL PROTEOMICS PROVIDES VIEW OF DISEASES AT EARLY STAGES
   
   Feb 02 | Bio-IT World | Researchers in Germany have developed a series of
   innovative solutions for probing the body more broadly and deeply for early
   pathological signs of diseases ranging from metabolic disorders and
   neurodegenerative diseases to cancer. Their novel technology, dubbed
   DISCO-MS, does spatial proteomics in three-dimensional (3D) intact specimens
   using a combination of whole-organ and whole-organism clearing and imaging,
   deep-learning-based image analysis, robotic tissue extraction, and
   ultrahigh-sensitivity mass spectrometry. More


 * RETINAL ORGANOID-DERIVED NEURONS TO POTENTIALLY CURE DEGENERATIVE EYE DISEASE
   
   Jan 31 | Bio-IT World | A new study published in the Proceedings of the
   National Academy of Science demonstrates the potential for lab-grown retinal
   neurons to reestablish synaptic function and cure neurodegenerative eye
   disease, according to researchers from the University of Wisconsin–Madison.
   More


 * TAKE THE DNA DELOREAN: THE PROMISE OF LARGE LANGUAGE MODELS IN GENOMICS
   
   Jan 27 | Bio-IT World | Information directly from DNA to understand RNA's and
   human proteins' downstream structure describes how our cells function in
   clear linguistic terms. Today, large language models demonstrate remarkable
   abilities to interpret, translate, summarize, and generate human languages.
   Now, we are finally generating the amount of data required to train such
   models in the language of biology. More


 * MICROSOFT APPLIES AI TO DIGITIAL CANCER PATHOLOGY IMAGING, WORLD’S FIRST
   NEXT-GENERATION SINGLE-MOLECULE PROTEIN SEQUENCING PLATFORM, MORE
   
   Jan 26 | Bio-IT World | A Salmonella-based bactofection platform to deliver
   RNA payloads to treat cancer patients; tRNA therapeutics capable of
   overcoming genetic errors to treat genetic diseases and cancer; the Jackson
   Laboratory enters an expansive and exclusive intellectual property licensing
   agreement across six areas of human health; and more. More


 * HOW RECURSION HOPES TO HARNESS THE BIG PICTURE VIEW TO UNDERSTAND BIOLOGY’S
   LANDSCAPE
   
   Jan 24 | Bio-IT World | In the latest episode of Trends from the Trenches
   podcast, host Stan Gloss of BioTeam sits down with Chris Gibson, co-founder
   and CEO of Recursion, to talk about Recursion’s mission to decode biology,
   radically improve lives, and set big goals to innovate across every stage of
   drug discovery. More


 * FOLLOW THE MONEY: UNIVERSITY OF CHICAGO FUNDS BIOTECH ACCELERATOR,
   BREAKTHROUGH TANKLESS INHALED NITRIC OXIDE DELIVERY SYSTEM, MORE
   
   Jan 24 | Bio-IT World | Funding for new therapeutic targets for a proprietary
   genetic medicines pipeline fueled by an automated discovery engine and
   versatile gene-editing toolbox, an in vivo engineered cell therapy platform
   for immuno-oncology genomic medicines, advanced therapeutic nucleic acids
   manufacturing, and more. More


 * HUATENG PHARMA SUPPLIES TETRAHYDROCURCUMIN WITH LARGE SCALE
   
   Feb 10 | About Huateng Pharma Huateng Pharma is a global provider in contract
   development and manufacturing for pharmaceutical intermediates. With our
   focus on operational excellence, and the integration of manufacturing
   operations with EHS, quality assurance, quality control, regulatory, supply
   chain management and project management, we can manufacture, scale-up and
   supply high-quality intermediates and APIs from our China facility. We have
   established a 5000 square meters R&D center and have our own manufacturing
   site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical
   Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City,
   Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district,
   Changsha, Hunan, China Email: sales@huatengusa.com Website:
   https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax:
   +86 0731-82251112-818 More


 * ONCODXRX EMERGES FROM STEALTH MODE WITH WORLD-FIRST PGA TECHNOLOGY
   
   Feb 10 | OncoDxRx's innovative technology, for the first time, brings two
   worlds together - from gene expression to drug efficacy. More


 * BSI LIFE SCIENCES AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS
   OPERATIONS
   
   Feb 09 | BSI Life Sciences specializes in state-of-the-art software for life
   sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology
   company focused on optimizing clinical operations in the areas of site
   budgeting and payments, announced their partnership today. Through the
   partnership, BSI Life Sciences’ Clinical Trial Management software BSI CTMS™
   and Ledger Run’s unique ClinRun™ platform will streamline and enhance
   clinical operation budgeting and payment processes with an intelligent
   approach and seamless integration. More


 * BOC SCIENCES ESTABLISHED LARGE-SCALE FERMENTATION TANKS OF DIFFERENT VOLUMES
   
   Feb 09 | More


 * AMERIGO SCIENTIFIC RELEASES OPTIMAL ZEDIXCLUSIVE TG6-AB ELISA (IGA) KITS TO
   DETECT TG6-AUTOANTIBODIES IN HUMAN SERA
   
   Feb 09 | Amerigo Scientific released ZediXclusive TG6-ab ELISA Kits (IgA),
   optimized based on ZediXplore TG6-ELISA Kits (IgA) to support celiac
   disease-related studies. More


 * ‘ZERO-COPY INTEGRATION’ INNOVATION FRAMEWORK PUBLISHED AS NATIONAL STANDARD
   OF CANADA
   
   Feb 09 | The new standard, called Zero-Copy Integration, provides a framework
   enabling companies to allow access to our information, rather than make
   copies of it, and allows controls be tied to the data itself over how and
   where it can be used. More


 * DECIBIO CONSULTING RANKS #1 IN INNOVATION IN THE VAULT CONSULTING 50 BEST
   FIRMS TO WORK FOR
   
   Feb 09 | DeciBio Consulting, a strategy consulting firm dedicated to
   accelerating the adoption and impact of precision medicine technologies,
   received recognition as a top consulting firm to work for in North America.
   DeciBio received first place in Innovation, achieving its first #1 ranking
   since its founding one decade ago. More


 * QUOTIENT SCIENCES EXPANDS FORMULATION DEVELOPMENT CAPABILITIES TO FURTHER
   ACCELERATE DRUG DEVELOPMENT TIMELINES
   
   Feb 09 | Company increases laboratory capacity to meet customer demand for
   fully integrated drug development capabilities More


 * ZEOMEGA RANKED #1 BEST IN KLAS FOR PAYER CARE MANAGEMENT SOLUTIONS
   
   Feb 09 | Company recognized as top performer based on Jiva Population
   Healthcare Enterprise Management Platform’s configurability, reliability, and
   functionality More


 * LYNIATE EARNS BEST IN KLAS® DISTINCTION FOR INTEGRATION ENGINE CATEGORY WITH
   OVERALL SCORES OF 95.7 AND 92
   
   Feb 08 | More

View more articles






Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development
cycles and 4X productivity gains to the world’s most advanced scientific R&D
organizations. Its process-centric experiment design, data capture, and data
analytics overcome the limitations of ELN and LIMS systems. Its adaptive data
integration engine delivers results that are always ready for machine learning.
Read more here!





Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at
the science, technology, and executive trends driving the life sciences through
conversations with industry leaders. BioTeam co-founder Stan Gloss brings years
of industry experience in science, data, and technology to conversations
exploring what is driving data and discovery, and what’s coming next.
Listen today!





Make your next clinical trial boring





Slope makes your clinical trials worry-free

--------------------------------------------------------------------------------

View More Industry Videos

×

×

 









250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com



Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

--------------------------------------------------------------------------------

Request Information

Privacy Policy